Evidence map›Paper›PMID 25703452›Full record

Trial reportClinical nutrition (Edinburgh, Scotland)2016

Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults.

Rupak Shivakoti, Parul Christian, Wei-Teng Yang, Nikhil Gupte, Noluthando Mwelase, Cecilia Kanyama, Sandy Pillay, Wadzanai Samaneka, Breno Santos, Selvamuthu Poongulali and 11 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical nutrition (Edinburgh, Scotland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02552602 (The Role of Multivitamins in Pediatric HIV Management in Nigeria), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02552602 naunknown statusnot on this map

The Role of Multivitamins in Pediatric HIV Management in Nigeria: A Randomized Controlled Study

TypeinterventionalSponsorRegina EsiovwaRan2015 to 2016Enrolled190ConditionsHIVArmsMultivitamin A, Multivitamin B, Multivitamin C
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Changes in Bone Mineral Density, Body Composition, Vitamin D Status, and Mineral Metabolism in Urban HIV-Positive South African Women Over 12 Months.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
    Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Role of Vitamin A in the Immune System.Journal of clinical medicine · 2018
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 14 institutions in 9 countries.

Rupak ShivakotiDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address: rshivak1@jhmi.edu.
Parul ChristianDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: pchrist1@jhu.edu.
Wei-Teng YangDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address: weiteng.yang@gmail.com.
Nikhil GupteDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address: nikhil_jhumit@yahoo.com.
Noluthando MwelaseDepartment of Medicine, University of Witwatersrand, Johannesburg, 2050, South Africa. Electronic address: tmwelase@witshealth.co.za.
Cecilia KanyamaUNC Lilongwe, Lilongwe, Private Bag A-104, Malawi. Electronic address: ckanyama@unclilongwe.org.
Sandy PillayDurban International Clinical Research Site, Durban University of Technology, Durban, 4001, South Africa. Electronic address: Pillay@ukzn.ac.za.
Wadzanai SamanekaUniversity of Zimbabwe Clinical Research Centre, Harare, 999, Zimbabwe. Electronic address: wsamaneka@uzcrc.co.zw.
Breno SantosHospital Nossa Senhora de Conceição, Porto Alegre, 91350-200, Brazil. Electronic address: breno@ghc.com.br.
Selvamuthu PoongulaliYR Gaitonde Center for AIDS Research and Education, Chennai, 600113, India. Electronic address: poongulali@yrgcare.org.
Srikanth TripathyNational AIDS Research Institute, Pune, 411026, India. Electronic address: directorjalma@gmail.com.
Cynthia RiviereLes Centres GHESKIO, Port-Au-Prince, HT-6110, Haiti. Electronic address: criviere@gheskio.org.
Sima BerendesMalawi College of Medicine-Johns Hopkins University Research Project, Blantyre, Malawi. Electronic address: sima.berendes@googlemail.com.
Javier R LamaAsociacion Civil Impacta Salud y Educacion, Lima, 4, Peru. Electronic address: jrlama@impactaperu.org.
Sandra W CardosoSTD/AIDS Clinical Research Laboratory, Instituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, 21045-900, Brazil. Electronic address: sandra.wagner@ipec.fiocruz.br.
Patcharaphan SugandhavesaResearch Institute for Health Sciences, Chiang Mai, 50200, Thailand. Electronic address: patcharaphan@rihes-cmu.org.
Alice M TangDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, 02111, MA, USA. Electronic address: Alice.Tang@tufts.edu.
Richard D SembaDepartment of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, 21287, MD, USA. Electronic address: rdsemba@jhmi.edu.
Thomas B CampbellDepartment of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO, 80045, USA. Electronic address: Thomas.Campbell@ucdenver.edu.
Amita GuptaDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address: agupta25@jhmi.edu.
NWCS 319 and PEARLS Study Team
Johns Hopkins University · USAsociación Civil Impacta Salud y Educación · PEChiang Mai University · THDurban University of Technology · ZAFundação Oswaldo Cruz · BRGheskio Centers · HTHospital Nossa Senhora da Conceição · BRLilongwe University of Agriculture and Natural Resources · MWNational AIDS Research Institute · INTufts University · USUniversity of Colorado Denver · USUniversity of the Witwatersrand · ZAUniversity of Zimbabwe · ZWYR Gaitonde Centre for AIDS Research and Education · IN

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)UM1AI068634 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Marlene Ann Cooper, Michael David Hughes · 2011 to 2026
$246.6M
AIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1M
Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trialsUM1AI106701 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$116.8M
UZ-UCSF CTUUM1AI069436 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ZVAVAHERA MIKE CHIRENJE, LYNDA STRANIX-CHIBANDA · 2012 to 2026
$75.9M
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit 2024 SupplementUM1AI069423 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, MINA CHRISTINE HOSSEINIPOUR · 2012 to 2026
$71.8M
UCLA AIDS Prevention and Treatment Clinical Trials UnitUM1AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Judith S. Currier, RAPHAEL J LANDOVITZ · 2012 to 2026
$51.8M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)UM1AI069465 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Charles W. Flexner, Amita Gupta · 2012 to 2026
$34.1M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)UM1AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI BEATRIZ GRINSZTEJN · 2012 to 2026
$26.3M
Colorado AIDS Clinical Trials UnitU01AI069450 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMPBELL, THOMAS B. · 2007 to 2011
$8.3M
PREVENTION MATERNAL TO INFANT HIV TRANSMISSION IN INDIAR01AI045462 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BOLLINGER, ROBERT C · 1999 to 2005
$5.8M
NIAID NIH HHS AI069450NIAID NIH HHS AI68636NIAID NIH HHS R01 AI045462NIAID NIH HHS R01 AI080417NIAID NIH HHS U01 AI068636NIAID NIH HHS U01 AI069450NIAID NIH HHS UM1 AI068634NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069450NIAID NIH HHS UM1 AI106701
6 · The paper itself

Abstract

BACKGROUND &

aimsHIV-infected adults have increased risk of several individual micronutrient deficiencies. However, the prevalence and risk factors of concurrent and multiple micronutrient deficiencies and whether micronutrient concentrations change after antiretroviral therapy (ART) initiation have not been well described. The objective of this study was to determine the prevalence and risk factors of individual, concurrent and multiple micronutrient deficiencies among ART-naïve HIV-infected adults from nine countries and assess change in micronutrient status 48 weeks post-ART initiation.

methodsA random sub-cohort (n = 270) stratified by country was selected from the multinational PEARLS clinical trial (n = 1571 ART-naïve, HIV-infected adults). We measured serum concentrations of vitamins A, D (25-hydroxyvitamin), E, carotenoids and selenium pre-ART and 48 weeks post-ART initiation, and measured vitamins B6, B12, ferritin and soluble transferrin receptor at baseline only. Prevalence of single micronutrient deficiencies, concurrent (2 coexisting) or conditional (a deficiency in one micronutrient given a deficiency in another) and multiple (≥3) were determined using defined serum concentration cutoffs. We assessed mean changes in micronutrient concentrations from pre-ART to week 48 post-ART initiation using multivariable random effects models.

resultsOf 270 participants, 13.9%, 29.2%, 24.5% and 32.4% had 0, 1, 2 and multiple deficiencies, respectively. Pre-ART prevalence was the highest for single deficiencies of selenium (53.2%), vitamin D (42.4%), and B6 (37.3%) with 12.1% having concurrent deficiencies of all three micronutrients. Deficiency prevalence varied widely by country. 48 weeks post-ART initiation, mean vitamin A concentration increased (p < 0.001) corresponding to a 9% decrease in deficiency. Mean concentrations also increased for other micronutrients assessed 48 weeks post-ART (p < 0.001) but with minimal change in deficiency status.

conclusionsSingle and multiple micronutrient deficiencies are common among HIV-infected adults pre-ART initiation but vary between countries. Importantly, despite increases in micronutrient concentrations, prevalence of individual deficiencies remains largely unchanged after 48 weeks on ART. Our results suggest that ART alone is not sufficient to improve micronutrient deficiency.

Indexed as

AdultAnti-Retroviral AgentsCarotenoidsCohort StudiesFemaleHIV InfectionsHumansLogistic ModelsMaleMalnutritionMicronutrientsMultivariate AnalysisPrevalenceRisk FactorsSeleniumVitamin AAnti-Retroviral AgentsCarotenoidsMicronutrientsSeleniumVitamin AVitamin DVitamin EAntiretroviral therapyCohort studiesHIVMicronutrient deficiencyMultiple micronutrientsVitamins

Identifiers

PMID25703452
PMCPMC4531105
OpenAlexW2026766565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.